Effect of cigarette smoking on Epithelial to Mesenchymal Transition (EMT) in lung cancer

Journal of Clinical Medicine

Volumn 5, Issue 4, 2016, Pages

  Vu, Trung ^a   Jin, Lin ^a   Datta, Pran K ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Cigarette smoke; Drug resistance; Epithelial to mesenchymal transition; Lung cancer; Metastasis

Indexed keywords

EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; POLYCYCLIC AROMATIC HYDROCARBON; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; VASCULOTROPIN RECEPTOR;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA SEQUENCE; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; METASTASIS; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; SMALL CELL LUNG CANCER; SMOKING; SMOKING CESSATION; TREATMENT RESPONSE;

EID: 85003831519     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5040044     Document Type: Review

References (116)

1. Lim, J.; Thiery, J. P. Epithelial to mesenchymal transitions: Insights from development. Development 2012, 139, 3471-3486. [PubMed]
2. Shook, D.; Keller, R. Mechanisms, mechanics and function of epithelial to mesenchymal transitions in early development. Mech. Dev. 2003, 120, 1351-1383. [PubMed]
3. Kalluri, R. EMT: When epithelial cells decide to become mesenchymal-like cells. J. Clin. Investig. 2009, 119, 1417-1419. [PubMed]
4. Kang, Y.; Massague, J. Epithelial to mesenchymal transitions: Twist in development and metastasis. Cell 2004, 118, 277-279. [CrossRef] [PubMed]
5. Singh, A.; Settleman, J. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 2010, 29, 4741-4751. [PubMed]
6. Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial to mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15, 178-219. [CrossRef] [PubMed]
7. Yilmaz, M.; Christofori, G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009, 28, 15-33. [CrossRef] [PubMed]
8. Liu, C. W.; Li, C. H.; Peng, Y. J.; Cheng, Y. W.; Chen, H. W.; Liao, P. L.; Kang, J. J.; Yeng, M. H. SNAIL regulates Nanog status during the epithelial to mesenchymal transition via the Smad1/AKT/GSK3beta signaling pathway in non-small-cell lung cancer. Oncotarget 2014, 5, 3880-3894. [CrossRef] [PubMed]
9. Merikallio, H.; Turpeenniemi-Hujanen, T.; Pääkkö, P.; Mäkitaro, R.; Riitta, K.; Salo, S.; Salo, T.; Harju, T.; Soini, Y. SNAIL promotes an invasive phenotype in lung carcinoma. Respir. Res. 2012, 13, 104-120. [CrossRef] [PubMed]
10. Hung, J. J.; Yang, M. H.; Hsu, H. S.; Hsu, W. H.; Liu, J. S.; Wu, K. J. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and SNAIL expression in resectable non-small cell lung cancer. Thorax 2009, 64, 1082-1089. [CrossRef] [PubMed]
11. Merikallio, H.; Pääkkö, P.; Mäkitaro, R.; Kaarteenaho, R.; Lehtonen, S.; Salo, S.; Salo, T.; Harju, T.; Soini, Y. H. SLUG is associated with poor survival in squamous cell carcinoma of the lung. Int. J. Clin. Exp. Pathol. 2014, 7, 5846. [PubMed]
12. Wushou, A.; Hou, J.; Zhao, Y. J.; Shao, Z. M. Twist-1 up-regulation in carcinoma correlates to poor survival. Int. J. Mol. Sci. 2014, 15, 21621-21630. [CrossRef] [PubMed]
13. Zeng, J.; Zhan, P.; Wu, G.; Yang, W.; Liang, W.; Lv, T.; Song, Y. Prognostic value of Twist in lung cancer: Systematic review and meta-analysis. Transl. Lung Cancer Res. 2015, 4, 236-241. [PubMed]
14. Nakashima, H.; Hashimoto, N.; Aoyama, D.; Kohnoh, T.; Sakamoto, K.; Kusunose, M.; Imaizumi, K.; Takeyama, Y.; Sato, M.; Kawabe, T.; et al. Involvement of the transcription factor twist in phenotype alteration through epithelial to mesenchymal transition in lung cancer cells. Mol. Carcinog. 2012, 51, 400-410. [CrossRef] [PubMed]
15. Merikallio, H.; Kaarteenaho, R.; Pääkkö, P.; Lehtonen, S.; Hirvikoski, P.; Mäkitaro, R.; Harju, T.; Soini, Y. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J. Clin. Pathol. 2011, 64, 136-140. [CrossRef] [PubMed]
16. Liu, L.; Chen, X.; Wang, Y.; Qu, Z.; Lu, Q.; Zhao, J.; Yan, X.; Zhang, H.; Zhou, Y. Notch3 is important for TGF-β-induced epithelial to mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Ther. 2014, 21, 364-376. [CrossRef] [PubMed]
17. Jiang, W.; Pang, X. G.; Wang, Q.; Shen, Y. X.; Chen, X. K.; Xi, J. J. Prognostic role of Twist, SLUG, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin. Lung Cancer 2012, 13, 280-290. [CrossRef] [PubMed]
18. Feng, J.; Zhang, X.; Zhu, H.; Wang, X.; Ni, S.; Huang, J. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS ONE 2012, 7, 39937-39947. [CrossRef] [PubMed]
19. Wei, L. X. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients. Tumor Biol. 2013, 34, 941-950. [CrossRef] [PubMed]
20. Xu, N. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PLoS ONE 2013, 8, 59412-59420. [CrossRef] [PubMed]
21. Kase, S.; Sugio, K.; Yamazaki, K.; Okamoto, T.; Yano, T.; Sugimachi, K. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin. Cancer Res. 2000, 6, 4789-4798. [CrossRef]
22. Zhang, X.; Liu, G.; Kang, Y.; Dong, Z.; Qian, Q.; Ma, X. N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS ONE 2013, 8, 57692-57700. [CrossRef] [PubMed]
23. Anttonen, A.; Leppä, S.; Ruotsalainen, T.; Alfthan, H.; Mattson, K.; Joensuu, H. Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2003, 41, 171-177. [CrossRef]
24. Liu, X. G. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol. 2012, 29, 618-630. [CrossRef] [PubMed]
25. Chen, D.; Zhang, Y.; Zhang, X.; Li, J.; Han, B.; Liu, S.; Wang, L.; Ling, Y.; Mao, S.; Wang, X. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-Related genes. Acta Histochem. 2013, 115, 128-238. [CrossRef] [PubMed]
26. Soltermann, A.; Tischler, V.; Arbogast, S.; Braun, J.; Probst-Hensch, N.; Weder, W.; Moch, H.; Kristiansen, G. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 2008, 14, 7430. [CrossRef] [PubMed]
27. Chen, Y.; Zou, L.; Zhang, Y.; Chen, Y.; Xing, P.; Yang, W.; Li, F.; Ji, X.; Liu, F.; Lu, X. Transforming growth factor-β1 and α-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection. Tumor Biol. 2014, 35, 6707-6720. [CrossRef] [PubMed]
28. Barrallo-Gimeno, A.; Nieto, M. A. The SNAIL genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005, 132, 3151-3161. [CrossRef] [PubMed]
29. Peinado, H.; Ballestar, E.; Esteller, M.; Cano, A. SNAIL mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24, 306-319. [CrossRef] [PubMed]
30. Herranz, N.; Pasini, D.; Díaz, V. M.; Francí, C.; Gutierrez, A.; Dave, N.; Escrivà, M.; Hernandez-Muñoz, I.; Di Croce, L.; Helin, K.; et al. Polycomb complex 2 is required for E-cadherin repression by the SNAIL1 transcription factor. Mol. Cell. Biol. 2008, 28, 4772-4781. [CrossRef] [PubMed]
31. Tong, Z. T.; Cai, M. Y.; Wang, X. G.; Kong, L. L.; Mai, S. J.; Liu, Y. H.; Zhang, H. B.; Liao, Y. J.; Zheng, F.; Zhu, W.; et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and SNAIL to inhibit E-cadherin. Oncogene 2012, 31, 583-594. [CrossRef] [PubMed]
32. Lin, T.; Ponn, A.; Hu, X.; Law, B. K.; Lu, J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial to mesenchymal transition. Oncogene 2010, 29, 4896-4904. [CrossRef] [PubMed]
33. Dong, C.; Wu, Y.; Yao, J.; Wang, Y.; Yu, Y.; Rychahou, P. G.; Evers, B. M.; Zhou, B. P. G9a interacts with SNAIL and is critical for SNAIL-mediated E-cadherin repression in human breast cancer. J. Clin. Investig. 2012, 122, 1469-1486. [CrossRef] [PubMed]
34. Dong, C.; Wu, Y.; Wang, Y.; Wang, C.; Kang, T.; Rychahou, P. G.; Chi, Y. I.; Evers, B. M.; Zhou, B. P. Interaction with Suv39H1 is critical for SNAIL-mediated E-cadherin repression in breast cancer. Oncogene 2013, 32, 1351-1362. [CrossRef] [PubMed]
35. Thuault, S.; Tan, E. J.; Peinado, H.; Cano, A.; Heldin, C. H.; Moustakas, A. HMGA2 and Smads coregulate SNAIL1 expression during induction of epithelial toto-mesenchymal transition. J. Biol. Chem. 2008, 283, 33437-33446. [CrossRef] [PubMed]
36. Smit, M. A.; Geiger, T. R.; Song, J. Y.; Gitelman, I.; Peeper, D. S. A Twist-SNAIL axis critical for TrkB-induced epithelial to mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol. Cell. Biol. 2009, 29, 3722-3737. [CrossRef] [PubMed]
37. Guaita, S.; Puig, I.; Franci, C.; Garrido, M.; Dominguez, D.; Batlle, E.; Sancho, E.; Dedhar, S.; De Herreros, A. G.; Baulida, J. SNAIL induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 2002, 277, 39209-39220. [CrossRef] [PubMed]
38. Saad, S.; Stanners, S. R.; Yong, R.; Tang, O.; Pollock, C. A. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the SNAIL transcription factor. Int. J. Biochem. Cell Biol. 2010, 42, 1115-1122. [CrossRef] [PubMed]
39. Yang, X.; Li, L.; Huang, Q.; Xu, W.; Cai, X.; Zhang, J.; Yan, W.; Song, D.; Liu, T.; Zhou, W.; et al. Wnt signaling through SNAIL1 and Zeb1 regulates bone metastasis in lung cancer. Am. J. Cancer Res. 2015, 5, 748-755. [PubMed]
40. Yang, J.; Mani, S. A.; Donaher, J. L.; Ramaswamy, S.; Itzykson, R. A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R. A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117, 927-939. [CrossRef] [PubMed]
41. Yang, F.; Sun, L.; Li, Q.; Han, X.; Lei, L.; Zhang, H.; Shang, Y. SET8 promotes epithelial to mesenchymal transition and confers TWIST dual transcriptional activities. EMBO J. 2012, 31, 110-123. [CrossRef] [PubMed]
42. Lo, H. W.; Hsu, S. C.; Xia, W.; Cao, X.; Shih, J. Y.; Wei, Y.; Abbruzzese, J. L.; Hortobagyi, G. N.; Hung, M. C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial to mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67, 9066-9076. [CrossRef] [PubMed]
43. Yang, M. H.; Wu, K. J. TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development. Cell Cycle 2008, 7, 2090-2096. [CrossRef] [PubMed]
44. Hong, J.; Zhou, J.; Fu, J.; He, T.; Qin, J.; Wang, L.; Liao, L.; Xu, J. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011, 71, 3980-3990. [CrossRef] [PubMed]
45. Postigo, A. A.; Dean, D. C. ZEB represses transcription through interaction with the corepressor CtBP. Proc. Natl. Acad. Sci. USA 1999, 96, 6683-6699. [CrossRef] [PubMed]
46. Sánchez-Tilló, E. E. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 2010, 29, 3490-3510. [CrossRef] [PubMed]
47. Postigo, A. A.; Depp, J. L.; Taylor, J. J.; Kroll, K. L. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 2003, 22, 2453-2463. [CrossRef] [PubMed]
48. Wang, J.; Scully, K.; Zhu, X.; Cai, L.; Zhang, J.; Prefontaine, G. G.; Krones, A.; Ohgi, K. A.; Zhu, P.; Garcia-Bassets, I.; et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446, 882-890. [CrossRef] [PubMed]
49. Dave, N.; Guaita-Esteruelas, S.; Gutarra, S.; Frias, À.; Beltran, M.; Peiró, S.; de Herreros, A. G. Functional cooperation between SNAIL1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 2011, 286, 12024-12034. [CrossRef] [PubMed]
50. Tsai, J. H.; Yang, J. Epithelial to mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013, 27, 2192-2200. [CrossRef] [PubMed]
51. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442-454. [CrossRef] [PubMed]
52. Doll, R.; Hill, A. B. Smoking and carcinoma of the lung: Preliminary report. Br. Med. J. 1950, 2, 739-748. [CrossRef] [PubMed]
53. Hecht, S. S.; Kassie, F.; Hatsukami, D. K. Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat. Rev. Cancer 2009, 9, 476-488. [CrossRef] [PubMed]
54. Parsons, A.; Daley, A.; Begh, R.; Aveyard, P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. BMJ 2010, 340, 5569. [CrossRef] [PubMed]
55. Kobrinsky, N. L.; Klug, M. G.; Hokanson, P. J.; Sjolander, D. E.; Burd, L. Impact of smoking on cancer stage at diagnosis. J. Clin. Oncol. 2003, 21, 907-913. [CrossRef] [PubMed]
56. Murin, S.; Inciardi, J. Cigarette smoking and the risk of pulmonary metastasis from breast cancer. Chest 2001, 119, 1635-1640. [CrossRef] [PubMed]
57. Abrams, J. A.; Lee, P. C.; Port, J. L.; Altorki, N. K.; Neugut, A. I. Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol. Biomark. Prev. 2008, 17, 2707-2713. [CrossRef] [PubMed]
58. McBride, S. M.; Ali, N. N.; Margalit, D. N.; Chan, A. W. Active tobacco smoking and distant metastasis in patients with oropharyngeal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84, 183-188. [CrossRef] [PubMed]
59. Moreira, D. M.; Aronson, W. J.; Terris, M. K.; Kane, C. J.; Amling, C. L.; Cooperberg, M. R.; Boffetta, P.; Freedland, S. J. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database. Cancer 2014, 120, 197-204. [CrossRef] [PubMed]
60. Fujisawa, T.; Iizasa, T.; Saitoh, Y.; Sekine, Y.; Motohashi, S.; Yasukawa, T.; Shibuya, K.; Hiroshima, K.; Ohwada, H. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J. Clin. Oncol. 1999, 17, 2086-2091. [PubMed]
61. Fox, J. L.; Rosenzweig, K. E.; Ostroff, J. S. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer 2004, 44, 287-293. [CrossRef] [PubMed]
62. Zhang, J.; Kamdar, O.; Le, W.; Rosen, G. D.; Upadhyay, D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am. J. Respir. Cell Mol. Biol. 2009, 40, 135-146. [CrossRef] [PubMed]
63. Shen, T.; Le, W.; Yee, A.; Kamdar, O.; Hwang, P. H.; Upadhyay, D. Nicotine induces resistance to chemotherapy in nasal epithelial cancer. Am. J. Rhinol. Allergy 2010, 24, 73-77. [CrossRef] [PubMed]
64. Warren, G. W.; Singh, A. K. Nicotine and lung cancer. J. Carcinog. 2013, 12, 135-146. [CrossRef] [PubMed]
65. Videtic, G. M.; Stitt, L. W.; Dar, A. R.; Kocha, W. I.; Tomiak, A. T.; Truong, P. T.; Vincent, M. D.; Yu, E. W. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J. Clin. Oncol. 2003, 21, 1544-1549. [CrossRef] [PubMed]
66. Sohal, S. S.; Reid, D.; Soltani, A.; Ward, C.; Weston, S.; Muller, H. K.; Wood-Baker, R.; Walters, E. H. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010, 15, 930-938. [CrossRef] [PubMed]
67. Milara, J.; Peiró, T.; Serrano, A.; Cortijo, J. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 2013, 68, 410. [CrossRef] [PubMed]
68. Sohal, S. S.; Mahmood, M. Q.; Walters, E. H. Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): Potential target for prevention of airway fibrosis and lung cancer. Clin. Transl. Med. 2014, 3, 33. [CrossRef] [PubMed]
69. Zhao, Y.; Xu, Y.; Li, Y.; Xu, W.; Luo, F.; Wang, B.; Pang, Y.; Xiang, Q.; Zhou, J.; Wang, X.; et al. NF-kappaB-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract. Toxicol. Sci. 2013, 135, 265-276. [CrossRef] [PubMed]
70. Wang, J.; Chen, Y.; Lin, C.; Jia, J.; Tian, L.; Yang, K.; Zhao, L.; Lai, N.; Jiang, Q.; Sun, Y.; et al. Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle. Am. J. Physiol. Cell Physiol. 2014, 306, 364-373. [CrossRef] [PubMed]
71. Sohal, S. S.; Walters, E. H. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir. Res. 2013, 14, 120. [CrossRef] [PubMed]
72. Siafakas, N. M.; Antoniou, K. M.; Tzortzaki, E. G. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int. J. Chron. Obstr. Pulm. Dis. 2007, 2, 453-462.
73. Fantozzi, A.; Gruber, D. C.; Pisarsky, L.; Heck, C.; Kunita, A.; Yilmaz, M.; Meyer-Schaller, N.; Cornille, K.; Hopfer, U.; Bentires-Alj, M.; et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res. 2014, 74, 1566-1575. [CrossRef] [PubMed]
74. Fowles, J.; Dybing, E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 2003, 12, 424-430. [CrossRef] [PubMed]
75. Dasgupta, P.; Rizwani, W.; Pillai, S.; Kinkade, R.; Kovacs, M.; Rastogi, S.; Banerjee, S.; Carless, M.; Kim, E.; Coppola, D.; et al. Nicotine induces cell proliferation, invasion and epithelial to mesenchymal transition in a variety of human cancer cell lines. Int. J. Cancer 2009, 124, 36-45. [CrossRef] [PubMed]
76. Dasgupta, P.; Rastogi, S.; Pillai, S.; Ordonez-Ercan, D.; Morris, M.; Haura, E.; Chellappan, S. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin. Investig. 2006, 116, 2208-2217. [CrossRef] [PubMed]
77. Schuller, H. M.; Plummer, H. K., 3rd; Jull, B. A. Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2003, 270, 51-58. [CrossRef] [PubMed]
78. Davis, R.; Rizwani, W.; Banerjee, S.; Kovacs, M.; Haura, E.; Coppola, D.; Chellappan, S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS ONE 2009, 4, 7524. [CrossRef] [PubMed]
79. Kommaddi, R. P.; Shenoy, S. K. Arrestins and protein ubiquitination. Prog. Mol. Biol. Transl. Sci. 2013, 118, 175-204. [PubMed]
80. Pillai, S.; Trevino, J.; Rawal, B.; Singh, S.; Kovacs, M.; Li, X.; Schell, M.; Haura, E.; Bepler, G.; Chellappan, S. Beta-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial to mesenchymal transition. Cancer Res. 2015, 75, 1009-1020. [CrossRef] [PubMed]
81. Zou, W.; Zou, Y.; Zhao, Z.; Li, B.; Ran, P. Nicotine-induced epithelial to mesenchymal transition via Wnt/beta-catenin signaling in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 304, 199-209. [CrossRef] [PubMed]
82. Wu, Z. Q.; Li, X. Y.; Hu, C. Y.; Ford, M.; Kleer, C. G.; Weiss, S. J. Canonical Wnt signaling regulates SLUG activity and links epithelial to mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc. Natl. Acad. Sci. USA 2012, 109, 16654-16659. [CrossRef] [PubMed]
83. Yan, W.; Shao, R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial to mesenchymal transformation. J. Biol. Chem. 2006, 281, 19700-19708. [CrossRef] [PubMed]
84. Wu, S. Q.; Lv, Y. E.; Lin, B. H.; Luo, L. M.; Lv, S. L.; Bi, A. H.; Jia, Y. S. Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial to mesenchymal transition in lung cancer cells. Mol. Med. Rep. 2013, 7, 875-880. [CrossRef] [PubMed]
85. Yoshino, I.; Kometani, T.; Shoji, F.; Osoegawa, A.; Ohba, T.; Kouso, H.; Takenaka, T.; Yohena, T.; Maehara, Y. Induction of epithelial to mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells. Cancer 2007, 110, 369-374. [CrossRef] [PubMed]
86. Ikuta, T.; Kawajiri, K. Zinc finger transcription factor SLUG is a novel target gene of aryl hydrocarbon receptor. Exp. Cell Res. 2006, 312, 3585-3594. [CrossRef] [PubMed]
87. Lin, P.; Chang, H.; Ho, W. L.; Wu, M. H.; Su, J. M. Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer 2003, 42, 255-261. [CrossRef]
88. Diry, M.; Tomkiewicz, C.; Koehle, C.; Coumoul, X.; Bock, K. W.; Barouki, R.; Transy, C. Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 2006, 25, 5570-5574. [CrossRef] [PubMed]
89. Valavanidis, A.; Vlachogianni, T.; Fiotakis, K. Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health 2009, 6, 445-462. [CrossRef] [PubMed]
90. Pfeifer, G. P.; Denissenko, M. F.; Olivier, M.; Tretyakova, N.; Hecht, S. S.; Hainaut, P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002, 21, 7435-7451. [CrossRef] [PubMed]
91. Mallozzi, C.; Di Stasi, A. M.; Minetti, M. Activation of src tyrosine kinases by peroxynitrite. FEBS Lett. 1999, 456, 201-206. [CrossRef]
92. Mehdi, M. Z.; Pandey, N. R.; Pandey, S. K.; Srivastava, A. K. H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid. Redox Signal. 2005, 7, 1014-1020. [CrossRef] [PubMed]
93. Zhang, H.; Liu, H.; Borok, Z.; Davies, K. J.; Ursini, F.; Forman, H. J. Cigarette smoke extract stimulates epithelial to mesenchymal transition through Src activation. Free Radic. Biol. Med. 2012, 52, 1437-1442. [CrossRef] [PubMed]
94. Liu, X.; Feng, R. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression. Acta Biochim. Biophys. Sin. 2010, 42, 496-501. [CrossRef] [PubMed]
95. Nagathihalli, N. S.; Massion, P. P.; Gonzalez, A. L.; Lu, P.; Datta, P. K. Smoking induces epithelial to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin. Mol. Cancer Ther. 2012, 11, 2362-2372. [CrossRef] [PubMed]
96. Park, S. M.; Gaur, A. B.; Lengyel, E.; Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22, 894-907. [CrossRef] [PubMed]
97. Liu, Y.; Luo, F.; Xu, Y.; Wang, B.; Zhao, Y.; Xu, W.; Shi, L.; Lu, X.; Liu, Q. Epithelial to mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract. Toxicol. Appl. Pharmacol. 2015, 282, 9-19. [CrossRef] [PubMed]
98. Zhao, W.; An, Y.; Liang, Y.; Xie, X. W. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 1930-1936. [PubMed]
99. Gupta, R. A.; Shah, N.; Wang, K. C.; Kim, J.; Horlings, H. M.; Wong, D. J.; Tsai, M. C.; Hung, T.; Argani, P.; Rinn, J. L.; et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464, 1071-1076. [CrossRef] [PubMed]
100. Wang, Q. Activation of uPAR is required for cigarette smoke extract-induced epithelial to mesenchymal transition in lung epithelial cells. Oncol. Res. 2013, 21, 295. [CrossRef] [PubMed]
101. Lund, L. R.; Ellis, V.; Rønne, E.; Pyke, C.; Danø, K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J. 1995, 310, 345-352. [CrossRef] [PubMed]
102. Duffy, M. J.; Duggan, C. The urokinase plasminogen activator system: A rich source of tumour markers for the individualised management of patients with cancer. Clin. Biochem. 2004, 37, 541-548. [CrossRef] [PubMed]
103. Nieder, C.; Bremnes, R. M. Effects of smoking cessation on hypoxia and its potential impact on radiation treatment effects in lung cancer patients. Strahlenther. Onkol. 2008, 184, 605-609. [CrossRef] [PubMed]
104. Sagone, A. L., Jr.; Lawrence, T.; Balcerzak, S. P. Effect of smoking on tissue oxygen supply. Blood 1973, 41, 845-850. [PubMed]
105. Nurwidya, F.; Takahashi, F.; Kobayashi, I.; Murakami, A.; Kato, M.; Minakata, K.; Nara, T.; Hashimoto, M.; Yagishita, S.; Baskoro, H.; et al. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial to mesenchymal transition in non-small cell lung cancer. Biochem. Biophys. Res. Commun. 2014, 455, 332-338. [CrossRef] [PubMed]
106. Shaikh, D.; Zhou, Q.; Chen, T.; Ibe, J. C.; Raj, J. U.; Zhou, G. cAMP-dependent protein kinase is essential for hypoxia-mediated epithelial to mesenchymal transition, migration, and invasion in lung cancer cells. Cell. Signal. 2012, 24, 2396-2400. [CrossRef] [PubMed]
107. Yang, M. H. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 2008, 10, 295-300. [CrossRef] [PubMed]
108. Eurlings, I. M.; Reynaert, N. L.; Van den Beucken, T.; Gosker, H. R.; de Theije, C. C.; Verhamme, F. M.; Bracke, K. R.; Wouters, E. F.; Dentener, M. A. Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1alpha in mesenchymal transition. PLoS ONE 2014, 9, 245-250. [CrossRef] [PubMed]
109. Shen, H. J.; Sun, Y. H.; Zhang, S. J.; Jiang, J. X.; Dong, X. W.; Jia, Y. L.; Shen, J.; Guan, Y.; Zhang, L. H.; Li, F. F.; et al. Cigarette smoke-induced alveolar epithelial to mesenchymal transition is mediated by Rac1 activation. Biochim. Biophys. Acta 2014, 1840, 1838-1849. [CrossRef] [PubMed]
110. Price, L. S.; Collard, J. G. Regulation of the cytoskeleton by Rho-family GTPases: Implications for tumour cell invasion. Semin. Cancer Biol. 2001, 11, 167-173. [CrossRef] [PubMed]
111. Yang, W. H.; Lan, H. Y.; Huang, C. H.; Tai, S. K.; Tzeng, C. H.; Kao, S. Y.; Wu, K. J.; Hung, M. C.; Yang, M. H. RAC1 activation mediates Twist1-induced cancer cell migration. Nat. Cell Boil. 2012, 14, 366-370. [CrossRef] [PubMed]
112. Liang, Z.; Xie, W.; Wu, R.; Geng, H.; Zhao, L.; Xie, C.; Li, X.; Huang, C.; Zhu, J.; Zhu, M.; et al. ERK5 negatively regulates tobacco smoke-induced pulmonary epithelial to mesenchymal transition. Oncotarget 2015, 6, 19605-19618. [CrossRef] [PubMed]
113. Nishimoto, S.; Nishida, E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006, 7, 782-786. [CrossRef] [PubMed]
114. Zuo, Y.; Wu, Y.; Wehrli, B.; Chakrabarti, S.; Chakraborty, C. Modulation of ERK5 is a novel mechanism by which Cdc42 regulates migration of breast cancer cells. J. Cell. Biochem. 2015, 116, 124-132. [CrossRef] [PubMed]
115. Zhou, C.; Nitschke, A. M.; Xiong, W.; Zhang, Q.; Tang, Y.; Bloch, M.; Elliott, S.; Zhu, Y.; Bazzone, L.; Yu, D.; et al. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial to mesenchymal transition phenotype. Breast Cancer Res. 2008, 10, 105-120. [CrossRef] [PubMed]
116. Schnoll, R.; Rothman, R.; Newman, H.; Lerman, C.; Miller, S. M.; Movsas, B.; Sherman, E.; Ridge, J. A.; Unger, M.; Langer, C.; et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: Implications for the development of tobacco control programs for cancer patients. Psycho-Oncol. 2004, 13, 346-358. [CrossRef] [PubMed]